Compile Data Set for Download or QSAR
Report error Found 28 of ki data for polymerid = 5537,5873,50000085
TargetAdenosine receptor A2(Bovine)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50438367(CHEMBL2413102)
Affinity DataKi:  11nMAssay Description:Displacement of [3H]CGS21680 from adenosine A2A receptor in bovine striatal membranes after 90 mins by liquid scintillation counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99205(US8501708, 29)
Affinity DataKi:  422nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99192(US8501708, 12)
Affinity DataKi:  476nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Human)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM108256(US8609833, 87 | CHEMBL2205239)
Affinity DataKi:  951nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99210(US8501708, 34)
Affinity DataKi:  2.27E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99193(US8501708, 13)
Affinity DataKi:  2.53E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99206(US8501708, 30)
Affinity DataKi:  2.55E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  2.77E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99202(US8501708, 22)
Affinity DataKi:  2.98E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99204(US8501708, 28)
Affinity DataKi:  3.37E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 15 | US8501708, 14)
Affinity DataKi:  3.74E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  3.78E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Human)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM97465(US8609833, 85 | US8470800, B)
Affinity DataKi:  4.19E+3nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAdenosine receptor A2(Human)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM97464(US8609833, 17 | US8470800, A | US8609833, 86)
Affinity DataKi:  4.69E+3nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99197(US8501708, 17)
Affinity DataKi:  5.32E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99199(US8501708, 19)
Affinity DataKi:  5.54E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99201(US8501708, 21)
Affinity DataKi:  6.83E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99198(US8501708, 18)
Affinity DataKi:  7.33E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Bovine)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50487424(CHEMBL2261733)
Affinity DataKi:  7.90E+3nMAssay Description:Displacement of [3H]CGS21680 from adenosine A2A receptor in Bos taurus (bovine) cortical membraneMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2020
Entry Details Article

TargetAdenosine receptor A2(Human)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM108258(US8609833, 91)
Affinity DataKi:  9.11E+3nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99203(US8501708, 23)
Affinity DataKi:  9.37E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Human)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM108257(US8609833, 88)
Affinity DataKi:  1.00E+4nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99200(US8501708, 20)
Affinity DataKi:  1.14E+4nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Bovine)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50487423(CHEMBL2261736)
Affinity DataKi:  1.50E+4nMAssay Description:Displacement of [3H]CGS21680 from adenosine A2A receptor in Bos taurus (bovine) cortical membraneMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2020
Entry Details Article

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99208(US8501708, 32)
Affinity DataKi:  1.56E+4nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 15 | US8501708, 14)
Affinity DataKi:  2.54E+4nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99196(US8501708, 16)
Affinity DataKi: >1.00E+5nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
US Patent

TargetAdenosine receptor A2(Human)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM97467(US8609833, 93 | US8470800, D)
Affinity DataKi: >1.00E+5nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent